Technological Advancement of Patient Monitoring Devices
Patient monitoring devices are used for the continuous monitoring or measurement of parameters such as heart rate or rhythm, respiratory rate, blood pressure, blood oxygen saturation, blood glucose and other parameters, where, accurate and immediate decision-making is crucial for effective patient care such as, in ICU, emergency, operation theatre, general ward, ambulatory surgical centers and home care settings. The patient monitoring devices are available in the form of single parameter monitoring such as Electroencephalography (EEG), Cerebral oximeter, intracranial pressure (ICP) monitors, magneto-encephalography (MEG) and electromyography machines (EMG), blood glucose monitors, Blood Pressure (BP), Blood Glucose, Electrocardiograph (ECG), pulse oximeter for oxygen saturation and others. Multi-parameter monitors are used for measuring multiple critical physiological signs of the patient to transmit vital information like ECG, respiration rate, blood pressure and others widely in ICU and general wards.
Technological advancements such as biosticker, artificial intelligence (AI), wearable patient monitoring devices, functional near-infrared spectroscopy (fNIRS), a tricorder phototype for diagnosis and monitoring of multi-parameter, smart speakers for monitoring cardiac arrest and wireless neonatal body monitors have led to patient monitoring devices that utilize faster, more accurate results. The technological advancements of patient monitoring devices helps to identify patients with high risk of disease. The Biosticker is a highly developed on-body sensor that allows for effortless continuous monitoring of vital signs and actionable insights delivered to clinicians from patients in the home setting, thereby creating unique opportunities for early detection of potentially preventable complications. Through the platform’s data sets and analytics, highly-efficient care is now achievable at a fraction of the cost of traditional remote patient monitoring devices. It is intended for use by healthcare professionals for continuous collection of physiological data at home and healthcare settings while the patient is at rest.
Leading healthcare providers in the United States and around the globe are experiencing firsthand how the latest artificial intelligence and machine learning solutions can improve patient care. Each stage of the patient care journey can be transformed with the right types of AI-assisted healthcare solutions and applications. Many of the healthcare providers and companies working with A.I. are making impacts on inference times, resource management, and remote patient monitoring. Using the latest technology, healthcare organizations can deliver a more accessible, personalized and enhanced care experience.
Wearable technology in healthcare includes electronic devices that consumers can wear and are designed to collect the data of the user’s health and exercise. The advancement of wearable technology and growing demand from consumers to take control of their health has influenced the medical industry, including insurers, providers and technology companies to develop more wearable devices. Wearable EEG Monitors, blood pressure monitors are the examples of wearable patient monitors, wearable sensors can detect hidden anxiety and depression in children.
Functional near-infrared spectroscopy (fNIRS) is a wearable and portable brain-monitoring technology that tracks and monitors the cortical hemodynamic response using near-infrared light sources and detectors placed over the scalp. It measures the changes of cortical deoxygenated and oxygenated hemoglobin concentrations non-invasively and safely in ecologically.
The tricorder is portable multi-functioning devices that diagnose, monitor and analyze several parameters such as diabetes, atrial fibrillation, chronic obstructive pulmonary disease, urinary tract infection, sleep apnea, leukocytosis, pertussis, stroke, tuberculosis, and pneumonia. The device is named as DxtER developed by Frontier Medical Devices as part of Basil Leaf Technologies. It’s a combination of smart tools, including a digital stethoscope, wrist sensor, chest sensor, spirometer and blood pressure calibrator that feeds an AI program data to provide accurate diagnoses.
Smart speakers like Google Home and Amazon Alexa, may detect the gasping sound of agonal breathing and call for help, the device is developed by the researchers at the University of Washington have developed a new tool to monitor patients for cardiac arrest while patients are asleep without touching them. The device works by continuously and passively monitoring the bedroom for an agonal breathing event, it detected agonal breathing events 97 percent of the time with almost no false alarms in a proof-of-concept study.
Neonates who are admitted to Neonatal Intensive Care (NICU) or Pediatric Intensive Care (PICU) are monitored through a complex collection of sensors and has a wire connected to a patient monitor. It is very difficult for parents to bond with their children and for clinicians to access the patients, hence Northwestern University engineers have developed flexible, wireless sensor patches that are capable of collecting the vital signs as wired devices. The new sensors can track the heart rate, respiration rate, temperature, and blood oxygenation as well as conventional sensors, and they also allow for monitoring of body movement and orientation, recording heart sounds, crying, and other audio biomarkers, and even provide a pretty accurate estimate of systolic blood pressure.
The Patient monitoring devices global market is expected to reach $42,974.9 million by 2027. The increase in the rate of surgeries and diseased population who requires continuous monitoring, increasing demand for portable and remote patient monitoring, increasing funding and investment in patient monitoring devices and technological advancements are driving the market growth.
Major players in the patient monitoring devices global market are Medtronic, PLC (Ireland), Dexcom, Inc. (U.S.), Masimo Corporation (Switzerland), Abbott Laboratories (U.S.), Nihon Kohden Corporation (Japan), Edwards Lifesciences Corporation (U.S.), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Hill-Rom Holdings, Inc. (U.S.), Natus Medical, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Dragerwerk AG & Co. KGaA (Germany).